ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

RMS Hermes International

2,251.00
-47.00 (-2.05%)
30 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Hermes International EU:RMS Euronext Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -47.00 -2.05% 2,251.00 2,244.00 2,300.00 2,303.00 2,245.00 2,300.00 71,927 16:47:55

Hermes Hit New Margin High in 1st Half, But 2Q Sales Slowed Amid China Lockdowns

29/07/2022 7:49am

Dow Jones News


Hermes (EU:RMS)
Historical Stock Chart


From May 2022 to May 2024

Click Here for more Hermes Charts.

By Joshua Kirby

 

Hermes International SCA on Friday maintained its medium-term growth goal as first-half earnings soared on record profitability and despite headwinds from lockdowns in China.

The luxury-fashion company, known for its exclusive handbags, made recurring operating income of 2.3 billion euros ($2.35 billion) in the first half of the year, up from EUR1.72 billion in the same period last year, and net profit of EUR1.64 billion. The recurring operating margin reached a new high of 42%, Hermes said.

Revenue in the half-year came in at EUR5.48 billion, decelerating in the second quarter to 20% growth at constant currency from 27% the previous quarter. In China, revenue was dragged by sanitary restrictions and store closures in April and May, but recovered strongly in June, Hermes said.

The company meanwhile booked its strongest growth in the U.S. where momentum continued, and in Europe, especially France, thanks to continued demand from local clients and a return of tourism.

The company set no targets for the full year, but said it remains confident of meeting its "ambitious" goal for constant-currency revenue growth over the medium term. "For 2022, the impacts of the health context are still difficult to assess," Hermes said.

 

Write to Joshua Kirby at joshua.kirby@wsj.com; @joshualeokirby

 

(END) Dow Jones Newswires

July 29, 2022 02:34 ET (06:34 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

1 Year Hermes Chart

1 Year Hermes Chart

1 Month Hermes Chart

1 Month Hermes Chart

Your Recent History

Delayed Upgrade Clock